Page last updated: 2024-11-06

prednisolone and Arrhythmogenic Right Ventricular Dysplasia

prednisolone has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Waki, H1
Eguchi, K1
Toriumi, S1
Ikemoto, T1
Suzuki, T1
Fukushima, N1
Kario, K1

Other Studies

1 other study available for prednisolone and Arrhythmogenic Right Ventricular Dysplasia

ArticleYear
Isolated Cardiac Sarcoidosis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy.
    Internal medicine (Tokyo, Japan), 2018, Mar-15, Volume: 57, Issue:6

    Topics: Anti-Inflammatory Agents; Arrhythmogenic Right Ventricular Dysplasia; Asian People; Cardiomyopathies

2018